LMH STRATEGIC SOLUTIONS

Lobbying for AVADEL PHARMACEUTICALS, PLC · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000.00 income · posted Oct 20, 2025

Bills named in this filing 2

Lobbying activity 1

Pharmacy

Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.